University of California San Francisco
Give to UCSFIn medical school, Nathan Lo thought we could do more to help the 750 million people around the world with or at risk of getting schistosomiasis. This week, he helped World Health Organization rewrite guidelines to treat everyone in affected communities.
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
A new study led by scientists at UCSF's Quantitative Biosciences Institute and University College London found that the Alpha variant of SARS-CoV-2 ramped up production of a protein that it uses to stifle infected cells’ immune-stimulating signals, helping it evade immune detection and accelerate its transmission.